Glowing dye to find lung tumors during surgery in teens
Treatments studied
Part of Cancer clinical trials.
This study tests a dye called ICG that makes cancer cells glow under a special camera. Doctors use it during surgery to find and remove lung tumors that have spread from another cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 17 years old.
- You have a solid tumor that has spread to your lungs, and you are scheduled for surgery to remove it.
- If you are female and able to have children, you must agree to use birth control during the study and for 30 days after.
- If you are male and sexually active, you must agree to use birth control during the study and for 30 days after.
- You do not have severe liver problems or a history of allergic reactions to the dye (ICG).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single dose of a special dye (LS301-IT) that helps surgeons see lung cancer cells more clearly during surgery. It aims to make lung cancer removal more precise and complete.
This early study tests using a special dye (indocyanine green, or ICG) to help surgeons find the correct “sentinel” lymph nodes during surgery in children with certain suspected tumors. If successful, it may improve how doctors remove and check lymph nodes while reducing the chance of missing important areas.
This trial tests a special imaging technique that uses a harmless dye to help surgeons see the exact boundary between healthy and diseased lung tissue during surgery to remove a small part of the lung. This could help make the surgery more precise and potentially preserve more healthy lung.
This early-stage study tests an intraoperative imaging approach called “TumorGlow” to help surgeons better identify tumor tissue during surgery. It may help improve the completeness of tumor removal and reduce the chance of recurrence in certain patients.
This trial tests a new way to plan and guide lung cancer surgery using a special dye that shows the tumor area during the operation. It may help surgeons remove the cancer more accurately while targeting only a small section of lung for certain early-stage patients.
This trial tests a dye called indocyanine green (ICG) that makes cancer cells glow under a special camera during surgery. It may help doctors remove more cancer and leave healthy tissue alone.
Hear when a new Sarcoma Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.